Expression of <i>GmNN1/FT2a</i> in various tissues of soybean plants. by Xinxin Li (281237)

Subjects:

GmNN1/FT2a interacted with GmNYFA-C in the BiFC assay. by Xinxin Li (281237)

Subjects:

Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia. by Francesca Catto (21253435)

“…<p>(A) Each 3-dimensional map of statistically affected voxels (p < 0.05, with the red scale, representing the significance in decrease of microglia, and the cyan scale, representing the increase in microglia; reference atlas is grey) summarizes all the treated and control samples within a cohort (3 samples per group). …”

The influence of wealth-signalling determinants on the adoption of improved seeds and fertilizers. by Aslihan Arslan (9393548)

Subjects:

The influence of select determinant subcategories on the adoption of improved agriculture technologies. by Aslihan Arslan (9393548)

Subjects:

A Novel Phospholipase A₁ Gene from Tritipyrum Improves Wheat Early Ripening and Salt Tolerance by Jv Zhang (11175243)

“…However, the malondialdehyde content decreased. Conversely, <i>TtPLA</i>_<i>1–1</i> downregulation in “Y1805” using a virus-induced gene silencing system decreased the salt tolerance. …”

A Novel Phospholipase A₁ Gene from Tritipyrum Improves Wheat Early Ripening and Salt Tolerance by Jv Zhang (11175243)

“…However, the malondialdehyde content decreased. Conversely, <i>TtPLA</i>_<i>1–1</i> downregulation in “Y1805” using a virus-induced gene silencing system decreased the salt tolerance. …”

Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Subjects:

Inhibiting caspase-3 did not improve oxidative stress in red blood cells. by Lu Han (151620)

DataSheet1_PagSOD2a improves poplar salt tolerance by elevating superoxide dismutase activity and decreasing malondialdehyde contents.zip by Lieding Zhou (16427928)

Select metabolites that are significantly altered in the <i>cop</i>^- strain when cultured in presence of 5 μM Cu(II)^b'*'. by Javiera Norambuena (137228)

Gene specific primers used for <i>GmNN1/FT2a</i> fine mapping. by Xinxin Li (281237)

Subjects:

Shematic representation for the mechanism of the swelling pressure: (a)soil without added fiber; (b)soil with added fiber. by Yonggang Huang (223155)

Subjects:

Results of the AEMG (2A) and MEMG (2B) of each muscle. by Yu Hashiguchi (14593059)

Subjects:

The expression of apoptosis in miR-133a-3p inhibitor and miR-133a-3p mimics transfected H9C2 cells. by Niu Liu (2104450)

Subjects:

Treatment with ICs causes a significant decrease in podocyte proliferation. by George Haddad (470789)

The expression of miR-133a-3p and CTGF in cardiac muscle. by Niu Liu (2104450)

Subjects:

<i>ogt-1; eel-1 +</i> Pan-neuronal OGT-1 have decreased sensitivity to electroshock and improved locomotion. by Nirthieca Suthakaran (11731101)

“…<p>Shown are each genotype ran through the electroconvulsive seizure assay for 3 seconds at 47V in saline control group. (A) Average time of recovery was significantly decreased in <i>ogt-1; eel-1</i> + Pan-neuronal OGT-1 worms, <i>Ogt-1(ok430) III; eel-1(bgg1) IV; bggSi2[Prab-3</i>::<i>ogt-1a] II</i> (n = 33), in comparison to <i>ogt-1;eel-1</i> double mutants (n = 30) but not significantly different from <i>eel-1</i> null mutants (n = 26). …”

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”